CLINICAL_TRIALS
trial_result
· 2011-03-11
Clinical Trial Update: A Multiple Dose Study Of PF-05161704 In Healthy Volunteers [Phase 1]
Summary
A Phase 1 multiple-dose study of PF-05161704 in healthy volunteers was terminated, according to the trial record.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: TERMINATED